CTLA4 and melanoma: The administration of anti–CTLA-4 does not demonstrate any effects on the restriction of lung metastasis of melanoma, however; concurrent use of this treatment with F10/g-vaccinated mice can result in suppressed lung colonization and eradicated pulmonary metastases via increased infiltration of mononuclear cells [139].